Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...
In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...
Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...
Weight-loss drug stocks were catapulted into the spotlight in 2024, creating a lucrative, groundbreaking, and high-stakes ...
Zepbound is a prescription injectable medication that’s used for weight loss. You or a caregiver can administer it as a subcutaneous injection into your stomach or thigh. A caregiver can also ...
which allows commercially insured patients without coverage for Zepbound to buy a month's supply for around $650. Under that program, patients whose commercial insurance plan covers Zepbound can ...